-
Deferoxamine Mesylate: Iron-Chelation Research Guide
2026-08-20
Deferoxamine mesylate is an iron-chelating agent that forms ferrioxamine and reduces the pool of chemically available iron. Research evidence supports its use in iron metabolism, oxidative stress protection, HIF-1α stabilization, and model-specific tissue or tumor studies, while the TCF25 study provides a separate framework for interpreting iron-linked lysosomal stress.
-
Cy5 maleimide (non-sulfonated): Protocol Guide
2026-08-20
Cy5 maleimide (non-sulfonated) is a thiol-reactive labeling reagent for attaching a Cy5 fluorophore to accessible cysteine residues in peptides and proteins. It is appropriate for site-directed fluorescence workflows but should not be selected for targets without accessible thiols or for protocols that require a water-soluble labeling reagent without an organic co-solvent.
-
2X HyperFusion High-Fidelity Master Mix Guide
2026-08-19
2X HyperFusion High-Fidelity Master Mix is a ready-to-use PCR formulation for high accuracy DNA amplification, cloning, and other workflows that benefit from proofreading. Its HyperFusion high-fidelity DNA polymerase combines processivity with 3′→5′ exonuclease proofreading and generates blunt-ended products, while the cited colorectal cancer study provides a separate biological context for accurate molecular construct preparation.
-
Syringin in RCC: EGFR/PI3K/Akt and Sunitinib
2026-08-19
A 2024 Journal of Functional Foods study identifies Syringin as an experimental inhibitor of renal cell carcinoma behavior and a potential enhancer of sunitinib response. By combining network pharmacology, molecular docking, bioinformatics, cell-based assays, and Western blotting, the authors connect these effects to EGFR/PI3K/Akt signaling and apoptosis.
-
DFO for Latent Fingerprint Detection
2026-08-18
DFO combines amino-acid reactivity with fluorescence to improve latent print visualization on paper and other porous evidence. This practical guide covers solvent selection, workflow controls, imaging optimization, troubleshooting, and the critical distinction between forensic DFO and deferoxamine mesylate used in biomedical research.
-
Mitochondrial IRF3 in Pulmonary Fibrosis
2026-08-18
A 2026 Cellular Signalling study identifies mitochondrial IRF3 as a mechanistic link between cGAS-STING activation, defective PINK1-associated mitophagy, and ferroptosis in alveolar epithelial cells. Its bleomycin-induced mouse model and TGF-β-stimulated A549 experiments suggest that limiting IRF3 mitochondrial translocation may offer a more specific strategy for pulmonary fibrosis research than targeting inflammation alone.
-
Luminescent ATP Detection Assay Kit for GBM
2026-08-17
Use the Luminescent ATP Detection Assay Kit for rapid, sensitive ATP profiling in glioblastoma cells, tissue lysates, and metabolic perturbation studies. Its gentle lysis workflow, 1 nM–10 μM linear range, and downstream protein compatibility make it a practical complement to PXDN–LDHA mechanistic experiments.
-
Rifampin for Mechanistic Bacterial Assays
2026-08-17
Rifampin is a rifamycin antibiotic for dissecting bacterial transcription, resistance evolution, and synthetic circuits. This article presents a causal assay framework that separates immediate RNA polymerase inhibition from later adaptive responses.
-
DiscoveryProbe FDA-approved Drug Library Workflow
2026-08-16
Learn how to use a clinically annotated compound collection for mechanism-led screening, secretion assays, and translational validation. This workflow emphasizes disease-relevant phenotypes, orthogonal confirmation, and practical troubleshooting rather than viability-only hit calling.
-
Parthenolide, ROS, and Apoptosis in Lymphoid Cancers
2026-08-15
Jorge and colleagues show that parthenolide reduces metabolic activity and promotes apoptosis across diverse B- and T-lineage lymphoid malignancy models, with increased reactive oxygen species, glutathione depletion, and mitochondrial membrane-potential loss. The study’s main value is its integrated use of resazurin-based metabolic profiling with flow-cytometric and gene-expression analyses, while also demonstrating why metabolic viability data require mechanistic confirmation.
-
Computational Models Reframe Mouse Depression Tests
2026-08-14
Li et al. introduce an automated tracking and computational modeling framework that resolves cognitive processes hidden by conventional immobility scoring in the forced swim and tail suspension tests. The study suggests that these assays share some mechanisms but are not interchangeable, with learning more influential early and consequence sensitivity becoming more important later.
-
LY2228820: From p38 Biology to Translational Insight
2026-08-14
A mechanistic and translational perspective on LY2228820, a selective p38 MAP kinase inhibitor, linking proximal target engagement to cytokine biology, tumor models, angiogenesis, and multiomics-driven study design.
-
Direct Mouse Genotyping Kit for Faster Screening
2026-08-13
Accelerate PCR amplification from mouse tissue by replacing routine DNA purification with optimized lysis, balancing, and direct template addition. The workflow is especially useful for mouse genetic screening, colony management, and high-throughput genotyping when the endpoint is a defined PCR band rather than purified genomic DNA.
-
Caspase-3–NDUFS1 Axis in Trichothecene Hepatotoxicity
2026-08-13
This preprint identifies caspase-3-mediated cleavage of the mitochondrial complex I subunit NDUFS1 as a mechanistic amplifier of ROS accumulation after exposure to deoxynivalenol and T-2 toxin. By connecting mitochondrial electron transport injury with ERO1α-dependent endoplasmic reticulum oxidative stress, the study provides a framework for interpreting trichothecene-induced liver damage and designing more discriminating mitochondrial assays.
-
Latrunculin A for Actin Dynamics Workflows
2026-08-12
Latrunculin A provides a rapid, reversible way to connect actin remodeling with substrate stiffness, growth-cone behavior, morphology, and motility. This workflow-oriented guide shows how to use controlled actin cytoskeleton disruption without confusing a downstream perturbation with direct evidence for Piezo1 signaling.